Skip to content

UK Declares Emergency Ban on Dangerous Puberty Blockers

In a commendable move echoing the concerns of many who prioritize the health and well-being of our children, the United Kingdom has instituted an “emergency ban” on the private prescription and supply of puberty blockers to minors. Both England and Scotland had already ceased offering these treatments to new patients under 18 due to the serious questions about side effects and the disturbing lack of data on their long-term effects. This recent decision further restricts private prescribers across England, Wales, and Scotland, as well as those in the European Economic Area and Switzerland, from administering these hormone-altering drugs to minors suffering from gender dysphoria, effective from June 3 to September 3.

This policy is a crucial step back from the precipice of irreversible medical interventions performed on children, who are arguably not of an age to consent to such life-altering decisions. The new regulations will prevent new patients under 18 from being prescribed these medicines for puberty suppression, aligning with guidelines already set by the National Health Service (NHS) in England.

Moreover, the NHS has taken a firmer stance, indefinitely restricting the prescription of these medicines within primary care settings, a decision grounded in patient safety concerns. This is a stark contrast to some practices in the United States, where radical and often untested gender transition treatments for minors have been promoted under the guise of progressive healthcare.

Children’s Health Must Come Before Progressive Ideologies

This action by the UK government is a response to the findings of the Cass Review, led by Dr. Hilary Cass, which starkly highlighted the “weak evidence” supporting the use of puberty blockers in minors. The review also pointed out the “insufficient/inconsistent” research regarding the effects of such treatments on long-term fertility and mental health outcomes.

It’s refreshing to see a government take steps to protect its youngest citizens from experimental treatments that could have irreversible consequences. This measure isn’t just about healthcare—it’s about safeguarding our children from potentially harmful medical experiments prompted more by ideology than by irrefutable scientific evidence.

Here in the States, we should take note. The push toward radical medical interventions for minors should be viewed with extreme caution. It’s imperative that we place the safety and future well-being of our children above the fray of woke agendas. The UK’s decision serves as a stark reminder that sometimes, true progress means stepping back and reevaluating the path forward, especially when it comes to our children’s health and future.

Robert B. Chernin

Robert B. Chernin

Robert is a longtime entrepreneur, business leader, fundraiser, and former radio talk show host. He studied political science at McGill University in Montreal and has spent over 25 years deeply involved in civic affairs at all levels. Robert has consulted on a variety of federal and statewide campaigns at the gubernatorial, congressional, senatorial, and presidential level. He served in leadership roles in the presidential campaigns of President George W. Bush as well as McCain for President. He led Florida’s Victory 2004’s national Jewish outreach operations as Executive Director. In addition, he served on the President’s Committee of the Republican Jewish Coalition.